stockportfolio.pro
Regeneron Pharmaceuticals, Inc. Gross Profit 2008–2025
Regeneron Pharmaceuticals, Inc. (REGN) annual gross profit by fiscal year, computed from SEC filings. Compound growth +21.1%/yr over 17 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | — | — | — |
| FY 2024 | — | — | — |
| FY 2023 | — | — | — |
| FY 2022 | — | — | — |
| FY 2021 | — | — | — |
| FY 2020 | — | — | — |
| FY 2019 | $6.15B | 93.9% | +25.4% |
| FY 2018 | $4.91B | 95.4% | -13.4% |
| FY 2017 | $5.67B | 96.6% | +21.5% |
| FY 2016 | $4.67B | 96.0% | +20.8% |
| FY 2015 | $3.86B | 94.1% | +43.5% |
| FY 2014 | $2.69B | 95.4% | +35.4% |
| FY 2013 | $1.99B | 94.4% | +53.5% |
| FY 2012 | $1.29B | 93.9% | +193.1% |
| FY 2011 | $441.61M | 99.1% | -3.4% |
| FY 2010 | $456.98M | 99.5% | +21.0% |
| FY 2009 | $377.58M | 99.6% | +59.0% |
| FY 2008 | $237.53M | 99.6% | — |
Source: Regeneron Pharmaceuticals, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Regeneron Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeRegeneron Pharmaceuticals, Inc. — frequently asked questions
What is Regeneron Pharmaceuticals, Inc.'s gross profit?
Regeneron Pharmaceuticals, Inc. (REGN) reported gross profit of $6.15B for fiscal year 2019, per its SEC filings.
How has Regeneron Pharmaceuticals, Inc.'s gross profit changed over time?
Between fiscal 2008 and 2025, REGN's gross profit grew at roughly 21.1% per year (compound annual rate), from $237.53M to $6.15B.
Where does this data come from?
Figures are computed from Regeneron Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.